Subconjunctival injection of stem cells reduces symptoms and modulates immune cell trafficking and differentiation in disease models.
Chinese researchers have confirmed that mesenchymal stem cells (MSCs) derived from human umbilical cord can reduce eye itching caused by grass pollen.Injecting mesenchymal stem cells subconjunctivally, but not intravenously, reduced the frequency of scratching and various clinical measures… + Read more
Cell therapy makes progress in allergic conjunctivitis
Subconjunctival injection of stem cells reduces symptoms and modulates immune cell trafficking and differentiation in disease models. + read more
They establish a method for large-scale production of cytotoxic T lymphocytes
This advance could make immunotherapy safer, more effective, and less expensive across multiple indications. + read more
New CAR-T lymphocytes drive progress in cell therapy for solid tumors
New genetic modifications and selection of optimal chimeric receptors will allow long-term treatment. + read more
Up to 40% of the population suffers from eye allergies
The 20th Annual Congress of the Spanish Society of Ocular Surface and Cornea (SESOC) highlights the most significant development of allergic conjunctivitis, a disease whose prevalence is increasing, affecting both children and adults and causing a significant deterioration in their quality of life . Sometimes, irreversible vision damage occurs. + read more
Pharmacological intervention may improve bone marrow transplant outcomes
Histone deacetylase inhibitors correct epigenetic imbalances in T lymphocytes following blood regeneration. + read more
Bacterial toxins provide protection in chronic allergic asthma model
It reduces airway inflammation and cellular changes characteristic of the disease through multiple immune mechanisms. + read more